Provider/Grant Support
This continuing education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Definium.
Credits Available
- Physicians — maximum of 0.50 AMA PRA Category 1 Credits™
- Pharmacists — 0.50 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry, as well as pharmacists who are involved in the management of patients with anxiety and/or depression.
Program Overview
Several psychedelic and psychedelic-adjacent therapies are advancing through late-stage clinical development, expanding the evidence base supporting their efficacy in the management of anxiety and depressive disorders. However, many clinicians remain unfamiliar with how these therapeutic models differ from conventional treatments and are uncertain about when these treatments may be appropriate for individual patients. In this CE podcast, expert faculty will distinguish emerging psychedelic therapies from currently available treatment options and outline practical, evidence-based approaches for integrating these therapies into routine care for patients with anxiety or depression.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
• Recognize how emerging psychedelic treatments differ from currently available options.
• Determine when psychedelic-based treatments may be appropriate for patients with anxiety or depression.
• Outline practical and evidence-based approaches to integrating emerging psychedelic therapies into routine care for patients with anxiety or depression.
Faculty
Philip D. Harvey, PhD (Activity Chair)
Leonard M. Miller Professor of Psychiatry and Behavioral Sciences
Vice Chair for Research
Director of the Division of Psychology
University of Miami Miller School of Medicine
Miami, FL
Gregory A. Fonzo, PhD
Assistant Professor
Co-Director, Charmaine & Gordon McGill Center for Psychedelic Research and Therapy
Department of Psychiatry and Behavioral Sciences
Mulva Clinic for the Neurosciences
Dell Medical School
The University of Texas at Austin
Austin, TX
Accreditation Statement
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
This program is acceptable for 0.50 contact hour(s) of ACPE Continuing Education Credit. The ACPE Universal Activity Number is JA0006104-0000-26-002-H01-P, effective 4/30/2026. This is a knowledge-based activity, and there is no fee to attend.
*IMPORTANT* Pharmacists MUST request credit within 60 days of activity completion. Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Disclosures of Conflict of Interest
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Dr. Philip D. Harvey, PhD (Activity Chair)
Consultant: Alkermes, BMS, Boehringer Ingelheim, Kynexis, Neurocrine Biosciences
Independent Research Contractor: Intra-Cellular Therapies
*Individual Stocks (privately held): i-Function, Inc.
Gregory A. Fonzo, PhD
Individual Stocks (publicly traded): Alto Neuroscience
*Will not discuss business lines or products of company(ies).
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Staff
Vindico Medical Education Staff
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Instructions for Participation and Credit
There are no fees for participating in and receiving CME credit for this enduring activity.
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credits™ certificate or CPE Statement of Credit.
Certificates will be immediately available to the participant.
Accessibility
Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.
Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at [email protected]. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.
Disclosure of Unlabeled Use
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Disclaimer
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Contact Information
For CME questions please contact: [email protected]